Engineered Swine Models of Cancer

Area of Science:

• Biomedical research
• Genetics
• Oncology

Background:

• Genetically modified swine technology has advanced significantly over the past decade.
• Swine physiology closely resembles human physiology, making them suitable biomedical models.
• Cancer models in swine are valuable for preclinical safety and toxicity testing of pharmaceuticals.

Purpose of the Study:

• To review the use of pigs as biomedical models in cancer research.
• To emphasize current technologies in creating swine cancer models.
• To highlight the potential applications and future opportunities of pigs in cancer modeling.

Main Methods:

• Review of current technologies for creating genetically modified swine.
• Focus on precision genetics, including targeted gene-editing.
• Application of custom endonucleases such as TALENs and CRISPRs, and transposon systems.

Main Results:

• Genetically engineered pigs can serve as valuable models for human cancer predisposition syndromes.
• Advanced gene-editing techniques allow for the creation of novel pig models of cancer.
• These models have broad preclinical applications for safety and toxicity studies.

Conclusions:

• Swine are immensely beneficial large animal models for cancer research.
• Precision genetics, particularly gene-editing technologies, are key to developing sophisticated cancer models in pigs.
• Utilizing pigs in cancer modeling presents significant future opportunities for biomedical research and drug development.